Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...
MedPage Today on MSN
New Injectable Approved for a Type of Kidney Disease
Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...
In this MedPage Today video, Sayna Norouzi, MD, of the Loma Linda University Medical Center in California, offers practical ...
Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.
May 11—(StatePoint) IgA nephropathy is a progressive, autoimmune, chronic disease that predominantly affects adults between the ages of 20 and 40, with an annual global incidence of 2.5 cases per ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Nephropathy is a kidney disease with ...
IgA nephropathy occurs when a certain immunoglobulin builds up in the kidneys, which can lead to blood in the urine and potential kidney damage. While no cure exists, treatments like blood pressure ...
Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback